|
PABPC4L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.446100E-04 |
| Normal-vs-Stage3 |
4.20180001903248E-10 |
| Normal-vs-Stage4 |
2.2866999999982E-05 |
| Stage1-vs-Stage2 |
6.184200E-01 |
| Stage1-vs-Stage3 |
1.69579999997893E-06 |
| Stage1-vs-Stage4 |
2.81859999784473E-08 |
| Stage2-vs-Stage3 |
4.981600E-02 |
| Stage2-vs-Stage4 |
1.872460E-02 |
| Stage3-vs-Stage4 |
2.376200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.65619999997957E-06 |
| Normal-vs-Asian |
3.394200E-02 |
| Caucasian-vs-AfricanAmerican |
5.341000E-01 |
| Caucasian-vs-Asian |
6.313800E-01 |
| AfricanAmerican-vs-Asian |
4.330200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.446200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.442380E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.216300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.658200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.379000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.982000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.321500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.731990E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.672800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.52700000000317E-05 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
3.462000E-02 |
| Grade 1-vs-Grade 2 |
2.746800E-01 |
| Grade 1-vs-Grade 3 |
2.004200E-04 |
| Grade 1-vs-Grade 4 |
6.77059996956331E-09 |
| Grade 2-vs-Grade 3 |
3.63859999999994E-05 |
| Grade 2-vs-Grade 4 |
2.75957035000829E-12 |
| Grade 3-vs-Grade 4 |
6.01150000000272E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
2.07529993190292E-10 |
| ccA subtype-vs-ccB subtype |
2.31120012017527E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62581059726108E-12 |
| Normal-vs-N1 |
3.646000E-01 |
| N0-vs-N1 |
2.133800E-02 |
|
|
